$70MSeries B, 10 March 2026
The oversubscribed Series B funds commercial readiness in Europe and the path to US approval.
- Amount
- $70M
- Stage
- Series B
- Announced
- 10 March 2026
- Lead
- Labcorp Venture Fund
- Other investors
- Mayo Clinic, Sutter Health, InterVest, PGGM, Puma Venture Capital, ROM Utrecht, Invest-NL, EIC Fund, NYBC Ventures, Sonder Capital
- Use of funds
- The oversubscribed Series B funds commercial readiness in Europe and the path to US approval.
- Checked
- Announced by the company
- Sources
- Vitestro raises $70M Series B for autonomous robotic blood draw tools.prnewswire.com
Vitestro raises $70M Series B for autonomous robotic blood draw pulse2.com